Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost

Investigative Ophthalmology & Visual Science
Dong-Jin OhDouglas J Rhee

Abstract

To determine the effect of latanoprost on the expression of human matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the ciliary body. Total RNA was isolated, and qualitative RT-PCR was performed to detect the mRNA of MMPs and TIMPs in human ciliary body tissue and explant cultures of ciliary body smooth muscle (CBSM) cells. CBSM cell cultures were treated with vehicle control or latanoprost acid for 24 hours. Quantitative RT-PCR of cell cultures from five different donors was performed to determine relative changes in expression. GAPDH served as an endogenous control. The mRNA of MMP-1, -2, -3, -11, -12, -14, -15, -16, -17, -19, and -24 as well as TIMP-1 to -4 were found in ciliary body tissue and CBSM cells. MMP-9 was present after latanoprost treatment. In control CBSM cells, the relative expression of MMP mRNA was MMP-2 and -14 > MMP-24 > MMP-1, -11, -15, -16, and -19 > MMP-3 and 17, > MMP-12. The relative expression of TIMP mRNA was TIMP-2 > TIMP-1 > TIMP-3 > TIMP-4. Latanoprost increased MMP-3 (in three of five cultures), MMP-17 (in four of five cultures), and TIMP-3 (in all five cultures); MMP-1, -2, -12, -14, -15, and -16 and TIMP-4 were downregulated. The transcription of the genes ...Continue Reading

Citations

Jul 14, 2009·Journal of Glaucoma·Efstathios T DetorakisMiltiadis K Tsilimbaris
Oct 31, 2008·The British Journal of Ophthalmology·N TeraiL E Pillunat
Apr 20, 2013·Investigative Ophthalmology & Visual Science·Dong-Jin OhDouglas J Rhee
Dec 24, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Nelson S Winkler, Michael P Fautsch
Jun 23, 2009·Survey of Ophthalmology·Xuyang LiuPaul L Kaufman
Dec 17, 2008·Survey of Ophthalmology·Carol B TorisPaul L Kaufman
Oct 22, 2008·Experimental Eye Research·Kathryn P B Cracknell, Ian Grierson
Jan 27, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Hyungwoo Lee, Byung Joo Cho
Apr 27, 2016·European Journal of Pharmacology·Padmanabhan P Pattabiraman, Carol B Toris
May 18, 2016·Journal of Cellular Physiology·Rahul MittalXue Zhong Liu
Apr 14, 2016·Ophthalmic Genetics·Lance P Doucette, Michael A Walter
Apr 3, 2020·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Robert N WeinrebW Daniel Stamer
Nov 28, 2020·Journal of Experimental Pharmacology·Viran JayanettiJed A Lusthaus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.